France

Long term, extension study of the safety and efficacy of AVP-786 for the treatment of agitation in patients with dementia of the Alzheimer's type

A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-design study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer’s type

Masitinib in patients with mild to moderate Alzheimer's disease

A study to assess efficacy and safety of KarXT for the treatment of psychosis associated with Alzheimer's disease dementia

A Phase 3, multicenter, randomised, double-blind, placebo-controlled study of the efficacy, safety and biomarker effects of ALZ-801 in subjects with early Alzheimer's disease and APOE4/4 genotype

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

Effect of caffeine on cognition in Alzheimer's disease

A randomised, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of BIIB080 in subjects with mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia

Donepezil versus non-drug treatment in Alzheimer's disease

A study to confirm safety and efficacy of BAN2401 in participants with early Alzheimer's disease

A study of potential disease modifying treatments in individuals at risk for or with a type of early onset Alzheimer’s disease caused by a genetic mutation (DIAN-TU)

A study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of DNL593 in healthy participants and participants with Frontotemporal Dementia (FTD-GRN)

A study to evaluate safety and tolerability of aducanumab in participants with Alzheimer's disease who had previously participated in the aducanumab studies 221AD103, 221AD301, 221AD302 and 221AD205

A study to verify the clinical benefit of Aducanumab in participants with early Alzheimer's disease

evoke - A research study investigating Semaglutide in people with early Alzheimer's disease

evoke+ - A research study investigating Semaglutide in people with early Alzheimer's disease

Therapeutic evaluation of low-dose IL-2-based immunomodulatory approach in patients with early Alzheimer's disease

A Phase 3 study to evaluate efficacy and safety of AL001 in frontotemporal dementia

A Phase 2 study to evaluate efficacy and safety of AL002 in rarticipants with early Alzheimer's disease

A prospective, multicenter, with a first randomised, placebo-controlled, parallel-group, double-blind period followed by an open-label trial period to evaluate the clinical safety and efficacy of NanoLithium® NP03 in patients with mild-to-severe Alzheimer’s disease: a proof-of-concept study

A study to test the efficacy, safety, and tolerability of bepranemab in patients with mild cognitive impairment or mild Alzheimer's disease

A Phase 2a study of TPN-101 in patients with C9ORF72 ALS/FTD